Skip to main content
Log in

Systemic administration of TIMP in the treatment of collagen-induced arthritis in mice

  • Animal Models
  • Published:
Agents and Actions Aims and scope Submit manuscript

Abstract

The type II collagen induced arthritis model was used to evaluate the efficacy of tissue inhibitor of metalloproteases (TIMP) in suppressing the disease in DBA/1 mice. Treatment began following the first clinical manifestations of the disease state. Clinical observations, histological and radiographic findings show a decreased incidence of joint erosion in the treated population relative to the controls. It is concluded that systemic administration of recombinant human TIMP suppresses the pathology of type II collagen induced arthritis.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. J. M. Stuart, A. S. Townes, and A. H. Kang, Ann. Rev. Immunol.2, 199–218 (1984).

    Google Scholar 

  2. J. M. Stuart, W. C. Watson and A. H. Kang, FASEB J.2, 2950–2956 (1988).

    Google Scholar 

  3. G. P. Stricklin and H. G. Welgus, J. Biol. Chem.258, 12252–12258 (1983).

    Google Scholar 

  4. D. F. Carmichael, A. Sommer, R. C. Thompson, D. A. Anderson, C. G. Smith, H. G. Welgus and G. P. Stricklin, Proc. Natl. Acad. Sci. USA,83, 2407–2411 (1986).

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Carmichael, D.F., Stricklin, G.P. & Stuart, J.M. Systemic administration of TIMP in the treatment of collagen-induced arthritis in mice. Agents and Actions 27, 378–379 (1989). https://doi.org/10.1007/BF01972827

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF01972827

Keywords

Navigation